Drugs and Implantable Cardioverter Defibrillators in Patients with Atrial Fibrillation and Heart Failure

  • P. Dini
  • F. Laurenzi
Conference paper


Atrial fibrillation (AF) and heart failure (HF) are two pathological conditions that frequently coexist.


Atrial Fibrillation Antiarrhythmic Drug Atrial Fibrillation Patient Persistent Atrial Fibrillation Atrial Tachycardia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW (1998) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction. J Am Coll Cardiol 32:695–703PubMedCrossRefGoogle Scholar
  2. 2.
    Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 155:469–473PubMedCrossRefGoogle Scholar
  3. 3.
    Ryder KM, Benjamin EJ (1999) Epidemiology and significance of atrial fibrillation. Am J Cardiol 84:131 R-138RCrossRefGoogle Scholar
  4. 4.
    Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306:1018–1022PubMedCrossRefGoogle Scholar
  5. 5.
    Middlekauff HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84:4048CrossRefGoogle Scholar
  6. 6.
    Jung F, Di Marco JP (1998) Treatment strategies for atrial fibrillation. Am J Med 104:272–286PubMedCrossRefGoogle Scholar
  7. 7.
    Wellens HJ, Lau CP, Luderitz B et al (1998) Atrioverter: an implantable device for treatment of atrial fibrillation. Circulation 98:1651–1656PubMedCrossRefGoogle Scholar
  8. 8.
    Daoud EG, Timmermanns C, Fellows C et al (2000) Initial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Metrix investigators. Circulation 102:1407–1413PubMedCrossRefGoogle Scholar
  9. 9.
    Timmermanns C, Levy S, Ayers G et al (2000) Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: observations on treated and non-treated episodes. Metrix investigators. J Am Coll Cardiol 35:1428–1433CrossRefGoogle Scholar
  10. 10.
    Schmitt C, Montero M, Melichercik J (1998) Significance of supraventricular tachyarrhhythmias in patients with implanted pacing cardioverter defibrillators. Pacing Clin Electrophysiol 17:295–302CrossRefGoogle Scholar
  11. 11.
    Best PJ, Hayes DL, Stanton MS (1999) The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 22:79–85PubMedCrossRefGoogle Scholar
  12. 12.
    Grimm W, Flores B, Marchlinski FE (1995) Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 6:832–851CrossRefGoogle Scholar
  13. 13.
    Swerdlow C, Schoels W, Dijkman B et al (2000) Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. Circulation 101:878–885PubMedCrossRefGoogle Scholar
  14. 14.
    Schoels W, Swerdlow DC, Jung W et al (2001) Worldwide clinical experince with a new dual-chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 12:521–528PubMedCrossRefGoogle Scholar
  15. 15.
    Adler SW II, Wolpert C, Warman EN et al (2001) Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 104:887–892PubMedCrossRefGoogle Scholar
  16. 16.
    Friedman PA, Dijkman B, Warman EN, et (2001) Atrial therapies reduce atrial arrhythmia burden in defibrillator patients.Circulation 104:1023–1028PubMedCrossRefGoogle Scholar
  17. 17.
    Gold MR, Sulke N, Schwartzman DS et al (2001) Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 12:1247–1253PubMedCrossRefGoogle Scholar
  18. 18.
    Lopez Gil M, Arribas F, Cosio FG (2000) Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy. Europace 2:327–332PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • P. Dini
    • 1
  • F. Laurenzi
    • 1
  1. 1.Department of CardiologyS. Camillo HospitalRomeItaly

Personalised recommendations